Abstract: Glass ceramic for use as a biomaterial comprising CaO 34.6 to 54.6%, SiO.sub.2 24.2 to 44.8 %, P.sub.2 O.sub.5 0 to 8.0%, CaF.sub.2 0.1 to 1.0% and Mgo 1.0 to 10.0% by weight and characterized by a primary wollastonite crystalline phase (CaO, SiO.sub.2) and a secondary apatite crystalline phase, and the process for the preparation thereof are disclosed. The glass ceramic of the present invention has superior mechanical properties, good biocompatibility, bioactivity, and no toxicity making it useful as a biomaterial in artificial bone and dental implants.